Market Overview

Blackstone's Vice Chairman Explains Why The Market Is Due For A Correction

Share:

Byron Wien, Blackstone's multi-asset investment group vice chairman, was a guest on CNBC and explained why he felt the stock market is due for a correction.

Wien pointed out that the stock market has seen gains nearly every single day since the 2016 election under the assumption that President Trump would implement his pro-growth agenda, including a tax cut, dismantling regulation and infrastructure spending. The markets also priced in Trump revising or replacing the Affordable Care Act - all of which remain uncertain at this time.

"Trump campaigned on increasing growth," Wien said. "He said he could get growth from 2 percent where it has been since the recession ended to 4 percent. It now looks like he won't get to 3 percent and 3 percent was what the market was counting on. And that's why the market is correction."

Disconnect Between Stocks And Economic Growth

Wien was then asked how he could justify his bold economic projection just 60 days into Trump's presidency. He said there is no way the economy can grow at 3 percent for the year unless there are immediate tax cuts and improvements in the regulatory environment.

Nevertheless, Wien has a 2,500 target on the S&P 500 by the end of the year as he believes despite any near-term stalls in changing the Affordable Care Act, eventually "something will pass." The same can be said for tax cuts that "something will pass."

"I think the market is headed to higher highs I just think that this glitch in Washington is going to be the catalyst that will cause the inevitable correction," he concluded.

See Also:

Pro: The Trump Rally May Have Come To An End

Investing Guru Byron Wien Says Diversification Is 'For The Weak-Minded'

Posted-In: Byron Wien CNBC Donald Trump health carePolitics Markets Media General

 

Related Articles (SPY)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Alzheimer's Pipeline In Focus At Oppenheimer Conference As Neurotrope's Trial Results Approach

IBM Is An 'Attractive Growth Story For Patient Investors'